|
|
AMLN
|
|
||
Re: Amylin and Takeda Discontinue Development of Pramlintide/Metreleptin Combination Treatment for Obesity Good, it will be much easier to sell the company now with just two platform products. See you at fifteen. |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
69800 | Re: Amylin and Takeda Discontinue Development of Pramlintide/Metreleptin Combination Treatment for Obesity | joeytakasugi | 0 | 8/5/2011 11:27:43 AM |